CD is confirmed by an IPS/P ratio of ≥2:1 at baseline, and/or a CRH-stimulated IPS/P ratio of ≥3:1 [37] in the setting of hypercortisolemia, usually defined by an elevated 24-h urinary free cortisol collected on the day prior to testing. Here, CRH is linked to adrenal gland hyperfunction.